酸中毒在结直肠恶性肿瘤中的研究进展

doi:10.11904/j.issn.1002-3070.2022.01.014

摘要/Abstract

摘要： 酸中毒是肿瘤微环境的标志之一,它与糖酵解、肿瘤的侵袭和转移密切相关,受多条分子通路的影响。既往结直肠肿瘤疾病的相关研究发现,酸中毒相关通路被激活是增加结直肠肿瘤细胞侵袭性的重要机制之一,同时亦可明显促进结直肠肿瘤的发生发展。靶向酸中毒治疗方式与传统治疗方式联合应用有望成为结直肠肿瘤疾病治疗的新方向。

关键词: 结直肠肿瘤, 酸中毒, 肿瘤侵袭, 治疗

Abstract: Acidosis is one of the hallmarks of tumor microenvironment.It is closely related to glycolysis,tumor invasion and metastasis,and is affected by multiple molecular pathways.Previous studies on colorectal neoplastic diseases have found that activation of acidosis-related pathways is important mechanisms to increase the aggressiveness of colorectal tumor cells,and it can also significantly promote the occurrence and development of colorectal tumors.The combined application of targeted acidosis treatment and traditional treatment is expected to become a new direction for the treatment of colorectal tumors.

Key words: Colorectal tumors, Acidosis, Tumor invasion, Treatment

中图分类号:

R735.3⁺5

王洋, 李国东, 汤庆超, 刘明. 酸中毒在结直肠恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2022, 36(1): 74-78.

WANG Yang, LI Guodong, TANG Qingchao, LIU Ming. Research progress of acidosis in colorectal malignant tumors[J]. Journal of Practical Oncology, 2022, 36(1): 74-78.

参考文献

1 Corbet C,Feron O.Tumour acidosis:from the passenger to the driver's seat[J].Nat Rev Cancer,2017,17(10):577-593.
2 Damaghi M,Gillies R.Phenotypic changes of acid-adapted cancer cells push them toward aggressiveness in their evolution in the tumor microenvironment[J].Cell Cycle,2017,16(19):1739-1743.
3 Kondo A,Yamamoto S,Nakaki R,et al.Extracellular acidic pH activates the sterol regulatory element-binding protein 2 to promote tumor progression[J].Cell Rep,2017,18(9):2228-2242.
4 Chiche J,Brahimi-Horn MC,Pouyssegur J.Tumour hypoxia induces a metabolic shift causing acidosis:a common feature in cancer[J].J Cell Mol Med,2010,14(4):771-794.
5 王春燕,谷巍,侯丽萍,等.β-HB、LAC、Lp-PLA2水平监测对糖尿病酮症酸中毒合并感染的影响[J].肿瘤代谢与营养电子杂志,2020,7(1):93-97.
6 Graziano F,Ruzzo A,Giacomini E,et al.Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer[J].Pharmacogenomics J,2017,17(3):258-264.
7 Brand A,Singer K,Koehl GE,et al.LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells[J].Cell Metab,2016,24(5):657-671.
8 Chang CH,Qiu J,O'Sullivan D,et al.Metabolic competition in the tumor microenvironment is a driver of cancer progression[J].Cell,2015,162(6):1229-1241.
9 Damaghi M,Tafreshi NK,Lloyd MC,et al.Chronic acidosis in the tumour microenvironment selects for overexpression of LAMP2 in the plasma membrane[J].Nat Commun,2015,6:8752.
10 Peppicelli S,Bianchini F,Calorini L.Extracellular acidity,a“reappreciated”trait of tumor environment driving malignancy:perspectives in diagnosis and therapy[J].Cancer Metastasis Rev,2014,33(2/3):823-832.
11 Katebi AR,Jernigan RL.The critical role of the loops of triosephosphate isomerase for its oligomerization,dynamics,and functionality[J].Protein Sci,2014,23(2):213-228.
12 Olivares-Illana V,Riveros-Rosas H,Cabrera N,et al.A guide to the effects of a large portion of the residues of triosephosphate isomerase on catalysis,stability,druggability,and human disease[J].Proteins,2017,85(7):1190-1211.
13 Roth U,Razawi H,Hommer J,et al.Differential expression proteomics of human colorectal cancer based on a syngeneic cellular model for the progression of adenoma to carcinoma[J].Proteomics,2010,10(2):194-202.
14 Peppicelli S,Toti A,Giannoni E,et al.Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation[J].Cell Cycle,2016,15(14):1908-1918.
15 Andreucci E,Peppicelli S,Carta F,et al.Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis[J].J Mol Med(Berl),2017,95(12):1341-1353.
16 Zhang J,Jiang W,Liu W,et al.Effective targeting of colorectal cancer cells using TORC1/2 kinase inhibitors in vitro and in vivo[J].Future Oncol,2016,12(4):515-524.
17 Wang G,Wang JJ,Yin PH,et al.New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy[J].J Cell Physiol,2018,234(1):348-368.
18 Moench R,Grimmig T,Kannen V,et al.Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer[J].Oncotarget,2016,7(42):68749-68767.
19 Gang W,Yu-Zhu W,Yang Y,et al.The critical role of calcineurin/NFAT(C/N)pathways and effective antitumor prospect for colorectal cancers[J].J Cell Biochem,2019,120(12):19254-19273.
20 Wu Y,Gao B,Xiong QJ,et al.Acid-sensing ion channels contribute to the effect of extracellular acidosis on proliferation and migration of A549 cells[J].Tumour Biol,2017,39(6):1010428317705750.
21 Zhou ZH,Song JW,Li W,et al.The acid-sensing ion channel,ASIC2,promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis[J].J Exp Clin Cancer Res,2017,36(1):130.
22 Wang G,Wang YZ,Yu Y,et al.Inhibitory ASIC2-mediated calcineurin/NFAT against colorectal cancer by triterpenoids extracted from Rhus chinensis Mill[J].J Ethnopharmacol,2019,235:255-267.
23 Lee M,Chen GT,Puttock E,et al.Mathematical modeling links Wnt signaling to emergent patterns of metabolism in colon cancer[J].Mol Syst Biol,2017,13(2):912.
24 Phillips CM,Zatarain JR,Nicholls ME,et al.Upregulation of cystathionine-β-synthase in colonic epithelia reprograms metabolism and promotes carcinogenesis[J].Cancer Res,2017,77(21):5741-5754.
25 Sprowl-Tanio S,Habowski AN,Pate KT,et al.Lactate/pyruvate transporter MCT-1 is a direct Wnt target that confers sensitivity to 3-bromopyruvate in colon cancer[J].Cancer Metab,2016,4:20.
26 Sun Y,Zhao X,Zhou Y,et al.miR-124,miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect[J].Oncol Rep,2012,28(4):1346-1352.
27 陈灿,张艳玲,刘小庆,等.miR-182对直肠癌细胞增殖、侵袭及Foxo3a/Wnt/β-catenin通路的调节作用[J].实用肿瘤学杂志,2020,34(4):328-333.
28 Taniguchi K,Ito Y,Sugito N,et al.Organ-specific PTB1-associated microRNAs determine expression of pyruvate kinase isoforms[J].Sci Rep,2015,5:8647.
29 Adeva M,Gonzalez-Lucan M,Seco M,et al.Enzymes involved in l-lactate metabolism in humans[J].Mitochondrion,2013,13(6):615-629.
30 Garufi A,Ricci A,Trisciuoglio D,et al.Glucose restriction induces cell death in parental but not in homeodomain-interacting protein kinase 2-depleted RKO colon cancer cells:molecular mechanisms and implications for tumor therapy[J].Cell Death Dis,2013,4:e639.
31 Vander Heiden MG,DeBerardinis RJ.Understanding the intersections between metabolism and cancer biology[J].Cell,2017,168(4):657-669.
32 Marin-Hernandez A,Gallardo-Perez JC,Rodriguez-Enriquez S,et al.Modeling cancer glycolysis[J].Biochim Biophys Acta,2011,1807(6):755-767.
33 Lozupone F,Borghi M,Marzoli F,et al.TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells[J].Oncogene,2015,34(40):5163-5174.
34 Corbet C,Bastien E,Santiago de Jesus JP,et al.TGFbeta2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells[J].Nat Commun,2020,11(1):454.
35 Hu PS,Li T,Lin JF,et al.VDR-SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment[J].Signal Transduct Target Ther,2020,5(1):183.
36 Javaeed A,Ghauri SK.MCT4 has a potential to be used as a prognostic biomarker-a systematic review and meta-analysis[J].Oncol Rev,2019,13(2):403.
37 Gharia B,Seegobin K,Mahida H,et al.Fatal type B lactic acidosis associated with metastatic colorectal cancer:a case report with review of literature,pathogenesis,and treatment[J].J Investig Med High Impact Case Rep,2018,6:2324709618788101.
38 Dhup S,Dadhich RK,Porporato PE,et al.Multiple biological activities of lactic acid in cancer:influences on tumor growth,angiogenesis and metastasis[J].Curr Pharm Des,2012,18(10):1319-1330.
39 Flaveny CA,Griffett K,El-Gendy Bel D,et al.Broad anti-tumor activity of a small molecule that selectively targets the warburg effect and lipogenesis[J].Cancer Cell,2015,28(1):42-56.
40 Pavlatovska B,Machalkova M,Brisudova P,et al.Lactic acidosis interferes with toxicity of perifosine to colorectal cancer spheroids:multimodal imaging analysis[J].Front Oncol,2020,10:581365.
41 Zhao M,Liu Q,Gong Y,et al.GSH-dependent antioxidant defense contributes to the acclimation of colon cancer cells to acidic microenvironment[J].Cell Cycle,2016,15(8):1125-1133.
42 Hu T,Liu H,Liang Z,et al.Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis[J].Theranostics,2020,10(9):4056-4072.

[1]	刘金爽, 张文静, 黎清炜, 李志伟. 免疫检查点抑制剂的联合治疗在胰腺癌中的研究进展[J]. 实用肿瘤学杂志, 2022, 36(1): 49-53.
[2]	张文静, 刘金爽, 王丹, 黎清炜, 李志伟. 胰腺癌新辅助治疗的研究现状[J]. 实用肿瘤学杂志, 2022, 36(1): 64-68.
[3]	李玉军, 刘丽洋, 肖娟娟, 薛华. 新诊断老年多发性骨髓瘤的预后分层及治疗进展[J]. 实用肿瘤学杂志, 2022, 36(1): 84-88.
[4]	徐丙臣, 曹洋森, 李健. 乳腺癌术后放疗H-IMRT技术与H-VMAT技术剂量学比较[J]. 实用肿瘤学杂志, 2021, 35(6): 511-516.
[5]	杨开炎, 韦永昌, 杨秋云, 唐凤珠. 鼻咽癌的免疫治疗研究进展[J]. 实用肿瘤学杂志, 2021, 35(6): 542-546.
[6]	李响, 胡洋, 张清媛. 肿瘤突变负荷作为乳腺癌免疫治疗的新兴生物标志物的研究进展[J]. 实用肿瘤学杂志, 2021, 35(6): 568-571.
[7]	马补换, 刘彩霞. Jagged1促进乳腺癌发生发展及远处转移的研究进展[J]. 实用肿瘤学杂志, 2021, 35(5): 452-457.
[8]	高科, 任明华. 去势抵抗性前列腺癌的药物治疗现状[J]. 实用肿瘤学杂志, 2021, 35(4): 376-379.
[9]	马明瑞, 连洁, 刘超, 娄长杰, 张艳桥. 消化系统肿瘤“免疫治疗前移”的探索[J]. 实用肿瘤学杂志, 2021, 35(3): 258-262.
[10]	黎敏, 冉立, 常建英. 影像学技术在图像引导宫颈癌近距离放射治疗中的应用[J]. 实用肿瘤学杂志, 2021, 35(3): 263-267.
[11]	提谦, 张清媛. CDK4/6抑制剂联合内分泌治疗晚期乳腺癌[J]. 实用肿瘤学杂志, 2021, 35(3): 287-290.
[12]	王萌萌, 连洁, 李恒震, 张艳桥. 胃肠胰神经内分泌肿瘤的免疫治疗研究进展[J]. 实用肿瘤学杂志, 2021, 35(2): 154-159.
[13]	秦伟, 何义富, 常娜, 钱立庭, 黄大兵, 崔亚云. 局部晚期宫颈癌放射治疗对直肠功能影响的研究进展[J]. 实用肿瘤学杂志, 2021, 35(2): 170-173.
[14]	王明明, 陈晓品. 抗PD-1/PD-L1和CTLA-4免疫治疗在头颈鳞癌中的研究进展[J]. 实用肿瘤学杂志, 2021, 35(2): 179-183.
[15]	胡洋, 张清媛. PARP抑制剂治疗BRCA1/2突变转移性乳腺癌的研究进展[J]. 实用肿瘤学杂志, 2021, 35(2): 184-187.